| Dr Puneet Kaur Chahal, MD | |
|
720 N Tustin Ave, 201, Santa Ana, CA 92705-3606 | |
| (714) 664-0045 | |
| (714) 664-0049 |
| Full Name | Dr Puneet Kaur Chahal |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 19 Years |
| Location | 720 N Tustin Ave, Santa Ana, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811155476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | A88986 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
| Orange County Global Medical Center | Santa ana, CA | Hospital |
| Foothill Regional Medical Center | Tustin, CA | Hospital |
| Chapman Global Medical Center | Orange, CA | Hospital |
| Hoag Orthopedic Institute | Irvine, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infectious Disease Associates Of Orange County Inc | 9234432915 | 6 |
News Archive
A major California hospital chain, Sutter Health, agreed to pay $46 million and disclose more pricing information to consumers to resolve a whistle-blower complaint alleging false and misleading charges for anesthesia. Sutter Health, which runs 24 acute-care hospitals in Northern California, said it reached the settlement Monday just prior to a trial starting this month over the allegations that it added thousands of dollars for "Code 37x" anesthesia charges that were already covered by other billing for the hospital operating room (Terhune, 11/4).
MSMB Capital Management today announced that it has made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
In a clinical trial of 220 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.
› Verified 6 days ago
| Entity Name | Infectious Disease Associates Of Orange County Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326403130 PECOS PAC ID: 9234432915 Enrollment ID: O20160129002112 |
News Archive
A major California hospital chain, Sutter Health, agreed to pay $46 million and disclose more pricing information to consumers to resolve a whistle-blower complaint alleging false and misleading charges for anesthesia. Sutter Health, which runs 24 acute-care hospitals in Northern California, said it reached the settlement Monday just prior to a trial starting this month over the allegations that it added thousands of dollars for "Code 37x" anesthesia charges that were already covered by other billing for the hospital operating room (Terhune, 11/4).
MSMB Capital Management today announced that it has made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
In a clinical trial of 220 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Puneet Kaur Chahal, MD 2321 E 4th St Ste C637, Santa Ana, CA 92705-3861 Ph: (714) 664-0045 | Dr Puneet Kaur Chahal, MD 720 N Tustin Ave, 201, Santa Ana, CA 92705-3606 Ph: (714) 664-0045 |
News Archive
A major California hospital chain, Sutter Health, agreed to pay $46 million and disclose more pricing information to consumers to resolve a whistle-blower complaint alleging false and misleading charges for anesthesia. Sutter Health, which runs 24 acute-care hospitals in Northern California, said it reached the settlement Monday just prior to a trial starting this month over the allegations that it added thousands of dollars for "Code 37x" anesthesia charges that were already covered by other billing for the hospital operating room (Terhune, 11/4).
MSMB Capital Management today announced that it has made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
In a clinical trial of 220 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.
› Verified 6 days ago
Dr. Meena Kumari Meka, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2740 S Bristol St Ste 208, Santa Ana, CA 92704 Phone: 714-979-5734 Fax: 562-426-9882 | |
Mr. Hon Yu, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2701 S Bristol St, Santa Ana, CA 92704 Phone: 714-210-2450 Fax: 714-210-2454 | |
Alan C Schwartz, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2621 S Bristol St, #307, Santa Ana, CA 92704 Phone: 714-918-3070 | |
Ranjit N Goonetilleke, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 999 N Tustin Ave, Suite 224, Santa Ana, CA 92705 Phone: 714-973-8522 | |
Quy Huu Nguyen, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1725 W 17th St, Santa Ana, CA 92706 Phone: 714-834-8017 Fax: 714-896-7316 | |
Dr. Nabil A Phillips, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1100 N Tustin Ave, Suite A, Santa Ana, CA 92705 Phone: 714-542-9100 Fax: 714-542-9105 | |
Dr. Ronald L Kaufman, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3 Imperial Promenade, Ste 300, Santa Ana, CA 92707 Phone: 714-428-6812 Fax: 714-242-7640 |